HLK-1002

N/A

Report date: 2025/03/11 17:16:30

Base Information

Drug NameHLK-1002
Drug Alias NameHLK-1002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHLK Pharmacin LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHLK Pharmacin LLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A